Enterprise Value
-51.52M
Cash
90.84M
Avg Qtr Burn
-17.48M
Short % of Float
2.65%
Insider Ownership
16.25%
Institutional Own.
67.75%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALG-055009 (THR-β Agonist) Details Non-alcoholic steatohepatitis | Phase 2a Initiation | |
ALG-000184 (Capsid Assembly modulator) Details Chronic hepatitis B | Phase 1/2 Update | |
ALG-097558 Details COVID-19 | Phase 1 Data readout | |
ALG-010133 (S-antigen Transport-inhibiting Oligonucleotide Polymer) Details Chronic hepatitis B | Failed Discontinued | |
ALG-125755 Details Chronic hepatitis B, Liver disease | Failed Discontinued |